15-Oct-2026      19:53

Parmax Pharma confirmed securities dematerialization to Indian exchanges, per SEBI regulations

Parmax Pharma Limited, with Scrip Code 540359, submitted a confirmation certificate dated October 1, 2026, to the Bombay Stock Exchange, National Securities Depository Limited, and Central Depository Services (India) Limited, regarding the dematerialization of securities for the quarter ended September 30, 2026, as per Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, with Purva Shareregistry (I) Private Limited acting as the Registrar and Share Transfer Agent.

News source: Capital Market - Live News